Cetera Investment Advisers
SNDX icon

Cetera Investment Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History

Cetera Investment Advisers’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Buy
36,443
+13,684
+60% +$285K ﹤0.01% 3254
2026
Q1 		$532K Sell
22,759
-357
-2% -$7.76K ﹤0.01% 3451
2025
Q4 		$486K Buy
+23,116
New +$403K ﹤0.01% 3468

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Cetera Investment Advisers's SNDX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Syndax Pharmaceuticals (SNDX) stake by 60% in Q2 2026, buying an estimated $285K and bringing the position to 36,443 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

Cetera Investment Advisers first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Cetera Investment Advisers held 36,443 shares of Syndax Pharmaceuticals worth $797K as of Q2 2026.
  • Cetera Investment Advisers bought 13,684 Syndax Pharmaceuticals shares in Q2 2026, an estimated $285K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3254 holding.
  • Cetera Investment Advisers first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.